Research compound · compound · checked 2026-10-09

Larazotide (AT-1001)

Larazotide (AT-1001) is listed here as a compound. Tight-junction-regulator peptide examined in celiac disease. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Larazotide (AT-1001) or how much to take.

Last checked Oct 9, 2026 by PepBear. Not medical advice.

FDA product
not established
Compounding
not established
Research
investigational
Sport
unknown

What is Larazotide (AT-1001)?

Other names in the library: AT-1001, Larazotide. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: no listed milligram sizes in the vendor file. A seller title is a listing. It does not prove the vial matches a paper.

Tight-junction-regulator peptide examined in celiac disease.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Compounding

not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.

Research

investigational. 342 adults with celiac disease and persistent symptoms while maintaining a gluten-free diet.

Sport

unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.

What the cited papers actually measured

We mark the cited papers as B for 342 adults with celiac disease and persistent symptoms while maintaining a gluten-free diet. and One experimental arm improved the primary symptom measure; other arms did not.. Mixed dose-ranging results. This is not permission to consume gluten, proof of general leaky-gut treatment, or evidence for an acetylated commercial blend. One experimental arm improved the primary symptom measure; other arms did not. Mixed dose-ranging results. This is not permission to consume gluten, proof of general leaky-gut treatment, or evidence for an acetylated commercial blend. Risks on the record: Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.

We mark the cited papers as B. That is our label for how strong those papers are. It does not say the compound works.

human-trial

One experimental arm improved the primary symptom measure; other arms did not.

342 adults with celiac disease and persistent symptoms while maintaining a gluten-free diet. Mixed dose-ranging results. This is not permission to consume gluten, proof of general leaky-gut treatment, or evidence for an acetylated commercial blend.

How long it lasts, how you store it, listed sizes

The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.

Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.

This card has no units chart until a milligram size is listed.

Risks and mix-ups already on the record

  • Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
  • No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
  • No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.

People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.

Sources

  1. Larazotide primary study · PMID 25683116 · checked 2026-10-09

Questions people ask

Is Larazotide (AT-1001) FDA-approved?

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Does PepBear pick an amount of Larazotide (AT-1001)?

The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.

Related cards

Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.